The 45-person company is focused on licensing real-world clinical databases from medical academies, organizing the data and building analytics tools…More
The deal follows by weeks Thermo Fisher’s acquisition, for $1.7 billion, of gene therapy contract manufacturing organization Brammer Bio.More
An investment analyst wrote that physicians see the results as potentially ushering in a “liquid-first” testing paradigm, but the liquid…More
The company, PathAI, intends to use the funds for expansion purposes as well as to enhance its offerings, improve its…More
The insurer said it will provide compensation for better care navigation based on quality and cost metrics across various parts…More
The company intends to use the funding, which came from Axioma Ventures, to advance its technology, differentiate product verticals and…More
Redox CEO Luke Bonney said the company saw more than 300 percent growth in its customer base over 2018 which…More
The deal comes days after Gilead partnered on clinical development in NASH with Denmark’s Novo Nordisk, and two months after…More
Philadelphia-based health data management startup HealthVerity recently raised a $25 million Series C financing round led by Foresite Capital.More
Sharpless pledged to continue the agency’s work promoting innovation and competition while tackling problems like vaccine avoidance and marketing of…More
